Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. announced that at its AGM held on May 30, 2023, declared payment of the final dividend for the year ended 31 December 2022 of RMB 0.07 per share (tax inclusive) was approved at the AGM, amounting to a total dividend of approximately RMB 72,560,047 (tax inclusive) (of which, the share capital of A Shares was 710,572,100 representing dividend to be paid is about RMB 49,740,047 and the share capital of H Shares is 326,000,000 representing dividend to be paid is about RMB 22,820,000). The final dividend is expected to be distributed on or before 25 August 2023 to all Shareholders whose names appear on the register of the Company on 12 June 2023.